Tissue Compartmentalization

Tissue compartmentalization describes how a drug partitions unevenly among the body's tissues rather than distributing uniformly. Some tissues are reached quickly because they are well perfused, others slowly because exchange is permeability-limited, and the amount that accumulates in each depends on local binding and composition. Representing the body as a set of tissue compartments is the basis of physiologically based pharmacokinetic modelling.

Definition

Tissue compartmentalization is the uneven partitioning of a drug among the body's tissues, determined by regional blood flow, membrane permeability, and tissue binding, and commonly represented by tissue:plasma partition coefficients within compartmental or physiologically based pharmacokinetic models.

Scope

This topic covers how drugs distribute into and accumulate within specific tissues: the difference between perfusion-limited and permeability-limited uptake, tissue:plasma partition coefficients, the role of tissue composition (lipid and protein content) in partitioning, and how these are assembled into compartmental and physiologically based models. It is a reference and educational entry and does not give dosing guidance.

Core questions

• Why does a drug distribute unevenly among different tissues rather than uniformly?
• What distinguishes perfusion-limited from permeability-limited tissue uptake?
• How do tissue:plasma partition coefficients quantify accumulation in a tissue?
• How is the body represented as tissue compartments in physiologically based models?

Key concepts

• Perfusion-limited versus permeability-limited distribution
• Tissue:plasma partition coefficients
• Tissue composition (lipid and protein content)
• Compartmental models
• Physiologically based pharmacokinetic (PBPK) modelling
• Tissue accumulation and redistribution

Mechanisms

A drug carried in arterial blood exchanges with each tissue at a rate set by that tissue's blood flow and the ease with which the drug crosses its capillary and cell membranes. In perfusion-limited tissues the membranes pose little resistance, so uptake tracks blood flow and equilibrium is reached quickly; in permeability-limited tissues slow membrane transfer governs uptake. The amount of drug that resides in a tissue at equilibrium is captured by the tissue:plasma partition coefficient, which depends on the tissue's lipid and protein content and on the drug's lipophilicity and binding. Physiologically based pharmacokinetic models assemble many such tissue compartments, each with its own blood flow and partition coefficient, to describe how a drug distributes throughout the body over time.

Clinical relevance

Tissue compartmentalization explains why drug concentrations differ between plasma and tissues and why some drugs accumulate in particular organs or redistribute over time. As a descriptive modelling concept it supports interpretation of pharmacokinetic profiles and the design of distribution studies; it is educational and not a basis for individual treatment decisions.

Evidence & guidelines

Tissue partitioning is characterised through experimental partition-coefficient measurements and physiologically based models; methods to predict tissue:plasma coefficients from tissue composition and drug properties are well established in the modelling and regulatory literature.

History

Compartmental description of drug distribution developed alongside classical pharmacokinetics, but the explicit representation of individual tissues matured with physiologically based pharmacokinetic modelling. Methods introduced around 2000 to predict tissue:plasma partition coefficients from tissue lipid and protein composition allowed these models to be parameterised from drug properties, and they have since become standard in drug development.

Key figures

• Patrick Poulin
• Frank-Peter Theil
• Hannah Jones

Seminal works

• poulin-2000
• poulin-2012
• jones-2013

Frequently asked questions

What is the difference between perfusion-limited and permeability-limited distribution?

In perfusion-limited tissues the drug crosses membranes easily, so uptake is governed by blood flow and equilibrium is fast; in permeability-limited tissues slow membrane transfer is the bottleneck, so uptake lags behind blood flow.

What does a tissue:plasma partition coefficient represent?

It is the ratio of drug concentration in a tissue to that in plasma at equilibrium, summarising how strongly the drug accumulates in that tissue based on the tissue's composition and the drug's binding and lipophilicity.